Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study.
Ulrich M, Reinhold U, Dominicus R, Aschoff R, Szeimies RM, Dirschka T. Ulrich M, et al. Among authors: aschoff r. J Am Acad Dermatol. 2021 Dec;85(6):1510-1519. doi: 10.1016/j.jaad.2021.03.031. Epub 2021 Mar 17. J Am Acad Dermatol. 2021. PMID: 33744350 Free article. Clinical Trial.
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U, Dirschka T, Ostendorf R, Aschoff R, Berking C, Philipp-Dormston WG, Hahn S, Lau K, Jäger A, Schmitz B, Lübbert H, Szeimies RM. Reinhold U, et al. Among authors: aschoff r. Br J Dermatol. 2016 Oct;175(4):696-705. doi: 10.1111/bjd.14498. Epub 2016 Jun 25. Br J Dermatol. 2016. PMID: 26921093 Clinical Trial.
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Morton CA, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Gröne D, Schulze HJ, Ockenfels HM, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach P, Gupta G, Hübinger F, Ziabreva I, Schmitz B, Gertzmann A, Lübbert H, Szeimies RM. Morton CA, et al. Among authors: aschoff r. Br J Dermatol. 2018 Aug;179(2):309-319. doi: 10.1111/bjd.16441. Epub 2018 May 16. Br J Dermatol. 2018. PMID: 29432644 Free article. Clinical Trial.
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
Dirschka T, Ekanayake-Bohlig S, Dominicus R, Aschoff R, Herrera-Ceballos E, Botella-Estrada R, Hunfeld A, Kremser M, Schmitz B, Lübbert H, Puig S. Dirschka T, et al. Among authors: aschoff r. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):288-297. doi: 10.1111/jdv.15185. Epub 2018 Aug 14. J Eur Acad Dermatol Venereol. 2019. PMID: 30022544 Free PMC article. Clinical Trial.
Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
Karrer S, Aschoff RAG, Dominicus R, Krähn-Senftleben G, Gauglitz GG, Zarzour A, Kerrouche N, Chavda R, Szeimies RM. Karrer S, et al. Among authors: aschoff rag. J Eur Acad Dermatol Venereol. 2019 Apr;33(4):661-666. doi: 10.1111/jdv.15422. Epub 2019 Feb 22. J Eur Acad Dermatol Venereol. 2019. PMID: 30633376
A 9-year-old boy with lichenoid skin lesions.
Lehr S, Aschoff R, Blau K, Heil J, Heyne S, Beissert S, Günther C. Lehr S, et al. Among authors: aschoff r. J Dtsch Dermatol Ges. 2023 Jan;21(1):77-79. doi: 10.1111/ddg.14935. Epub 2023 Jan 29. J Dtsch Dermatol Ges. 2023. PMID: 36709498 No abstract available.
56 results